Updated results of a phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM Meeting Abstract


Authors: Lim, M.; Ye, X.; Nabors, L. B.; Piotrowski, A.; Ahluwalia, M.; Desai, A.; Walbert, T.; Fisher, J.; Desideri, S.; Sims, M.; Wen, P.; Grossman, S.
Abstract Title: Updated results of a phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM
Meeting Title: 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 20
Issue: Suppl. 6
Meeting Dates: 2018 Nov 15-18
Meeting Location: New Orleans, LA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2018-11-01
Start Page: vi5
Language: English
ACCESSION: WOS:000460646300018
PROVIDER: wos
PMCID: PMC6216117
DOI: 10.1093/neuonc/noy148
Notes: Meeting Abstract: ATIM-21 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors